We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LRFC
1376
DELISTED
Logan Ridge Finance Corp
LRFC
| $862K | ﹤0.01% |
16,465
+8,499
| +107% | +$434K |
|
1377
Ionis Pharmaceuticals
IONS
$9.4B
| $855K | ﹤0.01% |
14,157
-1,843
| -12% | -$110K |
|
1378
InMode
INMD
$880M
| $854K | ﹤0.01% |
+43,550
| New | +$818K |
|
|
BCIC
1379
BCP Investment Corp
BCIC
$92.9M
| $854K | ﹤0.01% |
40,295
| – | – |
|
1380
e.l.f. Beauty
ELF
$5.81B
| $853K | ﹤0.01% |
+52,900
| New | +$880K |
|
|
PTVCB
1381
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
| $848K | ﹤0.01% |
+52,719
| New | +$859K |
|
1382
Old Republic International
ORI
$10.4B
| $846K | ﹤0.01% |
+37,800
| New | +$860K |
|
|
ZEPP
1383
Zepp Health
ZEPP
$69.7M
| $845K | ﹤0.01% |
+17,575
| New | +$737K |
|
1384
Brady Corp
BRC
$4.57B
| $836K | ﹤0.01% |
14,600
-36,000
| -71% | -$2.02M |
|
1385
Green Brick Partners
GRBK
$3.14B
| $836K | ﹤0.01% |
+72,846
| New | +$795K |
|
1386
Yum China
YUMC
$16.3B
| $816K | ﹤0.01% |
+17,000
| New | +$756K |
|
|
PACW
1387
DELISTED
PacWest Bancorp
PACW
| $815K | ﹤0.01% |
21,300
-23,176
| -52% | -$872K |
|
1388
Genie Energy
GNE
$383M
| $811K | ﹤0.01% |
104,888
+53,169
| +103% | +$417K |
|
1389
Dorman Products
DORM
$4.18B
| $810K | ﹤0.01% |
10,700
+2,000
| +23% | +$151K |
|
1390
Laureate Education
LAUR
$5.28B
| $810K | ﹤0.01% |
+45,978
| New | +$758K |
|
|
SBR
1391
Sabine Royalty Trust
SBR
$1.05B
| $803K | ﹤0.01% |
19,929
-20,774
| -51% | -$822K |
|
1392
Dolby
DLB
$5.79B
| $797K | ﹤0.01% |
11,587
+1,287
| +12% | +$85.2K |
|
1393
Bright Horizons
BFAM
$3.86B
| $789K | ﹤0.01% |
+5,252
| New | +$788K |
|
1394
REX American Resources
REX
$1.41B
| $779K | ﹤0.01% |
+57,000
| New | +$789K |
|
1395
Hamilton Beach Brands
HBB
$422M
| $776K | ﹤0.01% |
+40,641
| New | +$746K |
|
1396
SandRidge Energy
SD
$503M
| $775K | ﹤0.01% |
182,712
-312,179
| -63% | -$1.3M |
|
|
FLIR
1397
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $774K | ﹤0.01% |
14,858
-155,751
| -91% | -$8.25M |
|
|
FLNT
1398
Fluent
FLNT
$120M
| $772K | ﹤0.01% |
51,494
+28,374
| +123% | +$383K |
|
1399
Hyster-Yale Materials Handling
HY
$665M
| $772K | ﹤0.01% |
13,100
-727
| -5% | -$40.4K |
|
|
AVDL
1400
DELISTED
Avadel Pharmaceuticals
AVDL
| $771K | ﹤0.01% |
+102,171
| New | +$540K |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.